HCPLive

Most Patients Are Unaware of Out-of-Pocket Costs for Prostate Cancer Treatment

 
FRIDAY, Jan. 4 (HealthDay News) -- Most patients with localized prostate cancer know little about the out-of-pocket expenses (OOPE) of the different treatments, and would not have chosen a different treatment even if they had known the actual OOPE of their treatment, according to a study published in the December issue of Urology.

Olivia S. Jung, from Harvard Business School in Boston, and colleagues conducted a qualitative research study involving 41 patients with clinically localized prostate cancer enrolled from the urology and radiology practices of the University of Pennsylvania. Participants completed a semi-structured interview and questionnaire discussing the burden of OOPE, its effect on treatment decisions, and prior knowledge of OOPE.

Based on qualitative assessment, the researchers identified five major themes: "my insurance takes care of it;" "health is more important than cost;" "I did not look into it;" "I cannot afford it but would have chosen the same treatment;" and "it is not my doctor's business." Ninety-three percent of patients reported that, even if they had known the actual OOPE of their treatment, they would not have chosen a different treatment. A socioeconomically heterogeneous group reported feeling burdened by OOPE, and their choice of treatment was unaffected. Before choosing their treatment, only two of the patients reported knowing a lot about the likely OOPE for different treatments.

"Among insured patients with prostate cancer treated at a large academic medical center, few had knowledge of OOPE before making treatment choices," the authors write.
 

Abstract
Full Text (subscription or payment may be required)

 
Copyright © 2013 HealthDay. All rights reserved.
 

Most Popular

Recommended Reading

A recent study looked into the neural functions affected by ibuprofen and found some connections that may soon lead to a much greater understanding of the greatest pain mitigator of them all: the brain.
Discontinuation of multiple sclerosis medication saw nearly 2 in 5 patients experience some form of increased disease activity, according to research from NYU Langone Medical Center.
As more research is done the more it appears brown fat will play a key role in the future treatment of diabetes.
Weighing the pros and cons of prescription opioid use for chronic pain is an ongoing battle, and new research may have just added to the list of disadvantages.
$vAR$